Study of an Oral Fluid Testing Approach (NCT06891235)
Oral Fluid Testing to Assess Cannabis Non-Use in Remote Clinical Trials
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this study is to identify and evaluate oral fluid testing as a biologic measure of cannabis use days that can be assessed remotely. The researchers will conduct this fully virtual study among a community sample of 200 individuals aged 18-30 years who have used cannabis at least 1 time per week on average in the past 30 days. Participants will complete oral fluid (saliva) tests, urine tests, and Timeline Follow-back interviews (self-report) that indicate their recent cannabis use (delta-9-THC). Participants will present for 3 virtual study visits across \~3-4 weeks and be asked to complete activities in between: Study Visit 1 (Day 0; informed consent, baseline survey, TLFB interview), Study Visit 2 (\~Day 7; TLFB interview, urine testing), 6 days of at-home videorecorded oral fluid testing, Study Visit 3 (\~Day 21; TLFB interview, urine test, oral fluid test, survey, interview).
Who can join: Review the eligibility criteria below.
Location: Boston Children's Hospital — Boston, Massachusetts
Age range: 18 Years to 30 Years
🧪 Interventions in This Study
- Biologic testing for THC (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Boston Children's Hospital — Boston, Massachusetts
📞 Contact the Study Coordinator
Phone: (617) 355-8306
Email: lydia.shrier@childrens.harvard.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Cannabis Use
- Characterization of Endocannabinoid and Endogenous Opioid Levels in Adolescents With Cannabis Use Disorder — Aurora, Colorado
- Feasibility/Acceptability of a Brief Motivational Intervention for Frequent/High-Intensity Cannabis Use — Seattle, Washington
- Acute Effects of Cannabis on Cognition and Affect — Pullman, Washington
- Research Investigating Drug Effects-2 (RiDE-2) — Chicago, Illinois
- Smart Talk: Cannabis Awareness and Prevention Curriculum Evaluation — Palo Alto, California
- Lung Health and Breath Biomarkers: Acute Effects of Inhaled Cannabis — Lexington, Kentucky
Explore by condition: All Cannabis Use clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.